Cytokine gene expression after allogeneic bone marrow transplantation

Area of Science:

• Immunology
• Hematology
• Transplantation Science

Background:

• Cytokines from T lymphocytes, monocytes/macrophages, and fibroblasts are crucial for immune responses and graft-versus-host disease (GVHD).
• Dysregulated cytokine production is implicated as a primary mediator of acute GVHD clinical manifestations.

Purpose of the Study:

• To investigate cytokine gene expression patterns in patients undergoing allogeneic bone marrow transplantation (allo BMT).
• To determine the correlation between specific cytokine mRNA levels and the development and severity of GVHD.
• To assess the predictive value of cytokine gene expression for transplantation-related complications.

Main Methods:

• Analysis of peripheral blood mononuclear cells (PBMCs) for cytokine mRNA expression (IL-1 beta, IL-6, TNF-alpha, IL-2, IL-2 receptor alpha subunit) in GVHD patients.
• Evaluation of cytokine mRNA and protein expression in mixed lymphocyte cultures (MLC) from patients with severe complications.

Main Results:

• Increased mRNA expression of IL-1 beta, IL-6, and TNF-alpha was observed in PBMCs during GVHD, correlating with disease severity.
• Elevated cytokine mRNA levels were detectable before clinical GVHD onset.
• IL-2 mRNA was not detected in PBMCs of GVHD patients, but increased IL-2 and IFN-gamma mRNA/protein in MLC predicted severe complications.
• Increased IL-2 receptor alpha subunit mRNA was found in PBMCs during GVHD.

Conclusions:

• Inflammatory cytokines (IL-1 beta, IL-6, TNF-alpha) play a significant role in GVHD clinical manifestations.
• IL-2 and its receptor may be important in allogeneic responses, potentially via autocrine signaling.
• IL-2 and IFN-gamma gene expression in MLC can serve as a predictive marker for transplantation-related complications in BMT patients.